Call for Abstracts | Bacteriology Online Meetings | Bacteriology Virtual Conferences

Call for Abstract

Scientific Program

5^th International Conference on Bacteriology, will be organized around the theme “Advances and Challenges in Bacteriology during Covid-19 Pandemic”

Bacteriology 2020 is comprised of 17 tracks and 65 sessions designed to offer comprehensive sessions that address current issues in Bacteriology 2020.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Track 1:Bacterial physiology

Track 1-1Bacterial growth
Track 1-2Bacterial metabolism
Track 1-3Bacterial nutrition
Track 1-4Bacterial replication

Track 2:Veterinary Bacteriology

Track 2-1Animal health
Track 2-2Food safety
Track 2-3Preventive measures
Track 2-4Zoonoses

Track 3:Plant Bacteriology

Track 3-1Classification of plant- pathogenic bacteria
Track 3-2Epidemiology and control of bacterial plant diseases
Track 3-3Evolution of bacteriology pathogens
Track 3-4Future prospects in plant bacteriology

Track 4:Medical Bacteriology and Immunology

Track 4-1Immunodeficiency
Track 4-2Immunological host response to infections
Track 4-3Microbial
Track 4-4Tumour immunity
Track 4-5Viral pathogenesis

Track 5:Industrial Microbiology, Microbial Biotechnology and Future Bioindustries

Track 5-1Applications of viral vectors
Track 5-2Industrial processes end products
Track 5-3Bioprocess engineering and systems biology
Track 5-4Microfactories-microbial production

Track 6:Clinical Bacteriology

Track 6-1Bacterial clinical studies
Track 6-2Clinical Microbiology and Infection
Track 6-3Clinical trials of antibiotics

Track 7:Bacteriology in Public Health

Track 7-1MARS
Track 7-2Naturopathy for bacterial infections
Track 7-3Pharmacology of antibiotics

Bacterial vaginosis is an abnormal vaginal condition that is characterized by vaginal discharge and results from an overgrowth of atypical bacteria in the vagina. It is not a true bacterial infection but rather an imbalance of the bacteria that are normally present in the vagina. Usually treatment is with an antibiotic, such as clindamycin or metronidazole. BV is the most common vaginal infection in women of reproductive age. In the United States about 30% of women between the ages of 14 and 49 are affected. BV is linked to an imbalance of “good” and “harmful” bacteria that are normally found in a woman’s vagina. Bacterial vaginosis results from overgrowth of one of several bacteria naturally found in your vagina. Usually, "good" bacteria (lactobacilli) outnumber "bad" bacteria (anaerobes). But if there are too many anaerobic bacteria, they upset the natural balance of microorganisms in your vagina and cause bacterial vaginosis. BV is a polymicrobial clinical syndrome resulting from replacement of the normal hydrogen peroxide producing Lactobacillus sp. in the vagina with high concentrations of anaerobic bacteria (e.g., Prevotella sp. and Mobiluncus sp.), G. vaginalis, Ureaplasma, Mycoplasma, and numerous fastidious or uncultivated anaerobes. Some women experience transient vaginal microbial changes, whereas others experience them for longer intervals of time.